Schaken met de Dood plot
There are better cancer drugs, but they are also becoming more and more expensive. How should this medication be paid for and will it be available to everyone in the future? Internist-oncologist Jan Schellekens and head of the laboratory René Bernards are looking for financing for these extremely expensive medicines, because the hospital's budget has long been insufficient for this. Chess with Death follows the first three patients to undergo this experimental treatment. Can they handle the side effects? Will it be possible to provide the drugs to cancer patients on a large scale?